Managing multimorbidity can help people with dementia live better for longer
As people live longer with dementia, we must balance the benefits and harms of medical interventions to meet unique individual needs, writes Jay B Lusk Much attention has been paid to the development of new drug treatments for Alzheimer’s disease. Interventions to target the pathophysiology of the most common form of dementia are essential to tackle its rising public health burden. Amid intense debates about the effectiveness of anti-amyloid treatment for Alzheimer’s disease1 lies a stark reality highlighted by our study published in The BMJ (doi:10.1136/bmj-2024-083034).2 While dementia incidence is decreasing, prevalence continues to rise in the US, and more than one in 10 older people in the US now have a dementia diagnosis. People are living longer and people with dementia are no exception. The scientific and medical communities must redouble our efforts to reduce the burden of chronic disease among people with dementia. Global public health …
